Uday Utkarsha, Tadi Lakshmi Jyothi, Islam Zarmina, Mohanan Parvathy, Ghazanfar Shamas, Babar Maryam Salma, Ismail Sumayya
West Bengal University of Health Sciences, Kolkata, India.
Department of Microbiology, All India Institute of Medical Sciences, Bibinagar, India.
Ann Med Surg (Lond). 2022 Jul;79:103972. doi: 10.1016/j.amsu.2022.103972. Epub 2022 Jun 15.
As of 6 June 2022, a sum 25,782 of active cases and 524,701 deaths due to Coronavirus disease-19 (COVID-19) have been recorded in India. Stewing in the flares of the pandemic, Kerala is entwined in the wrath of multiple emerging infectious diseases. India, a home to 1.3 billion people, recently faced a devastating second wave of COVID-19 during May of 2021, with a ruckus of chronic shortage of medicine, oxygen supplies, ventilators, besides, being challenged by secondary infections and chronic health ailments. The state of Kerala, alone contributes to 50% COVID-19 caseload, besides, recent simultaneous outbreaks of Zika Virus Disease (ZVD), Nipah Virus Disease (NiVD) and Kala-azar (black fever) on July 8, September 5 and 8, 2021 respectively. Syndemicity and a high case fatality rates of these highly contagious diseases coupled with post infection sequelae, overwhelm the already fragile healthcare system. Thus, these lethal infectious diseases along with an anticipated third wave of COVID-19 pose a serious public health threat in and around South India. With this narrative review, we aim to discuss the challenges that the emergence of intersecting outbreaks of Zika, Nipah, Kala-azar presents with, in the nation, amidst the global pandemic of COVID-19 and provide recommendations so as to help alleviate the situation. The syndemicity of COVID-19 with other infectious diseases, calls for adequate surveillance and monitoring of diseases' outbreaks. To avoid the worst situations like pandemic, the health ministry, public and private health stakeholders in India should strengthen the public healthcare delivery system and providence of quick medical facilities to control the rate of mortality and morbidity during outbreaks.
截至2022年6月6日,印度已记录到25782例新冠病毒病(COVID-19)确诊病例以及524701例死亡病例。在疫情的肆虐下,喀拉拉邦正遭受多种新出现的传染病的侵袭。印度拥有13亿人口,近期在2021年5月遭遇了毁灭性的第二波新冠疫情,除了面临药品、氧气供应、呼吸机长期短缺的混乱局面外,还受到继发感染和慢性健康问题的挑战。仅喀拉拉邦就占了印度新冠病例总数的50%,此外,该邦还分别于2021年7月8日、9月5日和8日同时爆发了寨卡病毒病(ZVD)、尼帕病毒病(NiVD)和黑热病。这些高传染性疾病的共发流行以及高病死率,再加上感染后的后遗症,使本就脆弱的医疗系统不堪重负。因此,这些致命的传染病以及预期中的第三波新冠疫情对印度南部及其周边地区构成了严重的公共卫生威胁。通过这篇叙述性综述,我们旨在探讨在全球新冠疫情大流行背景下,印度国内寨卡、尼帕、黑热病交叉爆发所带来的挑战,并提供相关建议以帮助缓解这一局面。新冠疫情与其他传染病的共发流行,要求对疾病爆发进行充分的监测。为避免出现类似大流行这样的最坏情况,印度卫生部、公共和私立卫生利益相关方应加强公共医疗服务体系,并提供快速医疗设施,以控制疫情爆发期间的死亡率和发病率。